# COLchicine and Thiamine in Heart Failure Due to Ischemic Heart Disease

> **NCT05873881** · PHASE3 · RECRUITING · sponsor: **Hamilton Health Sciences Corporation** · enrollment: 2500 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Colchicine 0.5 MG
- **DRUG:** Colchicine placebo
- **DRUG:** Thiamine Mononitrate 300 mg

## Key facts

- **NCT ID:** NCT05873881
- **Lead sponsor:** Hamilton Health Sciences Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-29
- **Primary completion:** 2027-06
- **Final completion:** 2027-06
- **Target enrollment:** 2500 (ESTIMATED)
- **Last updated:** 2025-06-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05873881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05873881, "COLchicine and Thiamine in Heart Failure Due to Ischemic Heart Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05873881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*